Adenosine and its receptors in the pathogenesis and treatment of inflammatory skin diseases
Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G pr...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 May 2024
|
| In: |
International journal of molecular sciences
Year: 2024, Volume: 25, Issue: 11, Pages: 1-22 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms25115810 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25115810 Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/11/5810 
|
| Author Notes: | Luxia Chen, Xuan Lei and Karsten Mahnke |
| Summary: | Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G protein-coupled receptors (A1, A2A, A2B, and A3). Given the widespread expression of those receptors and their regulatory effects on multiple immune signaling pathways, targeting adenosine receptors emerges as a compelling strategy for anti-inflammatory intervention. Animal models of psoriasis, contact hypersensitivity (CHS), and other dermatitis have elucidated the involvement of adenosine receptors in the pathogenesis of these conditions. Targeting adenosine receptors is effective in attenuating inflammation and remodeling the epidermal structure, potentially showing synergistic effects with fewer adverse effects when combined with conventional therapies. What is noteworthy are the promising outcomes observed with A2A agonists in animal models and ongoing clinical trials investigating A3 agonists, underscoring a potential therapeutic approach for the management of inflammatory skin disorders. |
|---|---|
| Item Description: | Gesehen am 14.11.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms25115810 |